Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00187915 · ClinicalTrials.gov registry record · NA
Pilot Trial for Implementation of a MPA PK Monitoring Strategy
A NA study of Transplant, Kidney, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT00187915: Completed NA study of Transplant, Kidney, sponsored by University of Florida.
NCT00187915 is a NA study of Transplant, Kidney that has completed, run by University of Florida. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00187915, a NA study of Transplant, Kidney, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a prospective interventional trial of de novo renal transplant recipients, aiming to validate a strategy which combines the use of early post transplant MPA AUC sampling, and subsequent MPA trough level monitoring to implement MPA PK monitoring in a clinically applicable fashion.
Conditions Studied
Interventions
- DRUG Mycophenolate mofetil + Tacrolimus
- DRUG Mycophenolate mofetil + Cyclosporin
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2003-07 |
| Est. Completion | 2004-12 |
| Phase | NA |
What the finished NCT00187915 record still lists
NCT00187915 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Transplant, Kidney appearing as the primary indexed condition, and to 2 interventions - of which Mycophenolate mofetil + Tacrolimus is the first listed.
NCT00187915 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT00187915 about?
NCT00187915 is a clinical study titled "Pilot Trial for Implementation of a MPA PK Monitoring Strategy". This study is a prospective interventional trial of de novo renal transplant recipients, aiming to validate a strategy which combines the use of early post transplant MPA AUC sampling, and subsequent MPA trough level monitoring to implement MPA PK monitoring in a clinically applicable fashion.
What is the current status of trial NCT00187915?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2003-07. Estimated completion is 2004-12.
What conditions does trial NCT00187915 study?
This clinical trial studies the following conditions: Transplant, Kidney.
What interventions are being tested in trial NCT00187915?
The interventions under investigation include: Mycophenolate mofetil + Tacrolimus (DRUG), Mycophenolate mofetil + Cyclosporin (DRUG).
Who is sponsoring clinical trial NCT00187915?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00187915 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00187915's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia